跳至主要内容
临床试验/NL-OMON47255
NL-OMON47255已完成不适用

Genetic variations as predictors of outcome and toxicity in non-small-cell lung cancer patients undergoing chemoradiation or chemotherapy with platinum agents. - Pharmacogenetics lung cancer - PGx-Lung cancer

Sint Antonius Ziekenhuis0 个研究点目标入组 350 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
350

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Diagnosed with NSCLC (stage II-IV)
  • * Age *18 year
  • * Received or starting with chemoradiation or chemotherapy with platinating agents (carboplatin, cisplatin)

排除标准

  • * Unable to give informed consent
  • * Patients with cognitive impairment or those who are not able to read or write Dutch (because of difficulties in completing questionnaires)

研究者

相似试验

Genetic variations as predictors of outcome and... | 临床试验